Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04652076
Title GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or Pembrolizumab (GYNET)
Acronym GYNET
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors NETRIS Pharma
Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.